Glorincor Pharmaceuticals Bonds, 26% 17may2026, RUB (DFA) (4C569819)
Domestic bonds
Domestic bonds
Cbonds consolidates global bond, stock, ETF and indices data into a single platform — so you can analyze faster, make informed investment decisions and outperform the market
Get accessBond parameters,
prospectuses
Analyze the data in the most efficient way
Current & historical quotes from 400+ stock exchanges & OTC market
Credit ratings, financial reports
Explore the most comprehensive database
1 000 000
bonds
80 234
stocks
167 970
ETF & Funds
70 000
indices
Track your portfolio in the most efficient way
full data on over 900 000 bonds, 80 000 stocks, 116 000 ETF & Funds; powerful bond screener; over 350 pricing sources among stock exchanges & OTC market; ratings & financial reports; user-friendly interface; available anywhere via Website, Excel Add-in and Mobile app.
Register|
The Glorinkor company was founded in 2009 in Moscow as a consulting center to support foreign companies interested in investing in the Russian economy and developing business in the post-Soviet space. In 2015, GLORINCOR LLC was ...
The Glorinkor company was founded in 2009 in Moscow as a consulting center to support foreign companies interested in investing in the Russian economy and developing business in the post-Soviet space. In 2015, GLORINCOR LLC was established in the Republic of Belarus to accompany foreign investors in various industries. As a result, the choice was made to accompany high-tech companies from the healthcare industry. In 2017, agreements were signed with leading Asian biopharmaceutical companies on the registration and localization of biological and generic medicines in the field of treatment of oncological, endocrinological and autoimmune diseases. The list of medicines and health products is expanding and includes medicines of various pharmacotherapeutic groups, including drugs for the treatment of cardiovascular, infectious and neurological diseases. In 2022, Glorincor signed agreements on the registration and localization of vaccines for the immunization of children against diphtheria, tetanus, pertussis, hepatitis B, hemophilic infection type b.
|
|
|
|
|
|
|
|
|
Explore the most comprehensive database
1 000 000
bonds
80 234
stocks
167 970
ETF & Funds
70 000
indices
Track your portfolio in the most efficient way
full data on over 900 000 bonds, 80 000 stocks, 116 000 ETF & Funds; powerful bond screener; over 350 pricing sources among stock exchanges & OTC market; ratings & financial reports; user-friendly interface; available anywhere via Website, Excel Add-in and Mobile app.
Register| 2025 | |
| 2024 | |
| 2023 | |
| 2022 | |
| 2021 | |
| 2020 | |
| 2019 | |